申请人:H. Lundbeck A/S
公开号:US20020032205A1
公开(公告)日:2002-03-14
The present invention relates to benzofuran derivatives having general Formula (I)
1
wherein A is selected from (1), (2), (3), (4)
2
wherein
Z is O or S; s is 0 or 1; q is 0 or 1; R
4
is hydrogen, C
1-6
-alkyl, C
2-6
-alkenyl, C
2
6
-alkynyl, C
1-6
-alkyl-aryl, or C
1-6
-alkyl-O-aryl; D is a spacer group selected from branched or straight chain C
1-6
-alkylene, C
2-6
-alkenylene and C
2-6
-alkynylene; its enantiomers, and pharmaceutically acceptable acid addition salt thereof. The compounds are potently binding to the 5-HT
1A
receptor.
本发明涉及具有一般式(I)的苯并呋喃衍生物,其中A从(1),(2),(3),(4)中选择,其中Z为O或S;s为0或1;q为0或1;R4为氢,C1-6-烷基,C2-6烯基,C2-6炔基,C1-6烷基-芳基或C1-6烷基-O-芳基;D是从支链或直链C1-6-烷基,C2-6-烯基和C2-6-炔基中选择的间隔基;其对映体和药学上可接受的酸加成盐。这些化合物具有与5-HT1A受体的强结合能力。